Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Decreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa.

Wong M, Shiau S, Yin MT, Strehlau R, Patel F, Coovadia A, Micklesfield LK, Kuhn L, Arpadi SM.

J Pediatr. 2016 May;172:103-9. doi: 10.1016/j.jpeds.2016.01.034. Epub 2016 Feb 26.

PMID:
26922104
2.

Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy.

Giandhari J, Basson AE, Sutherland K, Parry CM, Cane PA, Coovadia A, Kuhn L, Hunt G, Morris L.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2248-56. doi: 10.1128/AAC.02682-15. Print 2016 Apr.

PMID:
26833162
3.

Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.

Pinillos F, Dandara C, Swart M, Strehlau R, Kuhn L, Patel F, Coovadia A, Abrams E.

BMC Infect Dis. 2016 Feb 2;16(1):56. doi: 10.1186/s12879-016-1381-x.

4.

Diagnosing childhood pulmonary tuberculosis using a single sputum specimen on Xpert MTB/RIF at point of care.

Gous N, Scott LE, Khan S, Reubenson G, Coovadia A, Stevens W.

S Afr Med J. 2015 Nov 10;105(12):1044-8. doi: 10.7196/SAMJ.2015.v105i12.8585.

PMID:
26792163
5.

Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial.

Coovadia A, Abrams EJ, Strehlau R, Shiau S, Pinillos F, Martens L, Patel F, Hunt G, Tsai WY, Kuhn L.

JAMA. 2015 Nov 3;314(17):1808-17. doi: 10.1001/jama.2015.13631.

6.

"I get hungry all the time": experiences of poverty and pregnancy in an urban healthcare setting in South Africa.

Scorgie F, Blaauw D, Dooms T, Coovadia A, Black V, Chersich M.

Global Health. 2015 Aug 25;11:37. doi: 10.1186/s12992-015-0122-z.

7.

The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy.

Salimo AT, Ledwaba J, Coovadia A, Abrams EJ, Technau KG, Kuhn L, Morris L, Hunt GM.

J Virol Methods. 2015 Oct;223:30-2. doi: 10.1016/j.jviromet.2015.07.005. Epub 2015 Jul 17.

PMID:
26192603
8.

Genetic Changes in HIV-1 Gag-Protease Associated with Protease Inhibitor-Based Therapy Failure in Pediatric Patients.

Giandhari J, Basson AE, Coovadia A, Kuhn L, Abrams EJ, Strehlau R, Morris L, Hunt GM.

AIDS Res Hum Retroviruses. 2015 Aug;31(8):776-82. doi: 10.1089/AID.2014.0349. Epub 2015 Jun 4.

PMID:
25919760
9.

Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.

Kuhn L, Schramm DB, Shiau S, Strehlau R, Pinillos F, Technau K, Coovadia A, Abrams EJ, Puren A, Tiemessen CT.

AIDS. 2015 Jun 1;29(9):1053-60. doi: 10.1097/QAD.0000000000000677.

10.

Discontinuation of cART postpartum in a high prevalence district of South Africa in 2014.

Claessens L, Voce A, Knight S, Sartorius B, Coovadia A.

Implement Sci. 2014 Oct 3;9:139. doi: 10.1186/s13012-014-0139-3.

11.

Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.

Hunt GM, Morris L, Moorthy A, Coovadia A, Abrams EJ, Strehlau R, Kuhn L, Persaud D.

J Virol Methods. 2014 Oct;207:182-7. doi: 10.1016/j.jviromet.2014.07.010. Epub 2014 Jul 14.

12.

Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis.

Kuhn L, Hunt G, Technau KG, Coovadia A, Ledwaba J, Pickerill S, Penazzato M, Bertagnolio S, Mellins CA, Black V, Morris L, Abrams EJ.

AIDS. 2014 Jul 17;28(11):1673-8. doi: 10.1097/QAD.0000000000000261.

13.

Timing of maternal HIV testing and uptake of prevention of mother-to-child transmission interventions among women and their infected infants in Johannesburg, South Africa.

Technau KG, Kalk E, Coovadia A, Black V, Pickerill S, Mellins CA, Abrams EJ, Strehlau R, Kuhn L.

J Acquir Immune Defic Syndr. 2014 Apr 15;65(5):e170-8. doi: 10.1097/QAI.0000000000000068.

14.

Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.

Shiau S, Kuhn L, Strehlau R, Martens L, McIlleron H, Meredith S, Wiesner L, Coovadia A, Abrams EJ, Arpadi SM.

BMC Pediatr. 2014 Feb 12;14:39. doi: 10.1186/1471-2431-14-39.

15.

Plasma lopinavir concentrations predict virological failure in a cohort of South African children initiating a protease-inhibitor-based regimen.

Moholisa RR, Schomaker M, Kuhn L, Meredith S, Wiesner L, Coovadia A, Strehlau R, Martens L, Abrams EJ, Maartens G, McIlleron H.

Antivir Ther. 2014;19(4):399-406. doi: 10.3851/IMP2749. Epub 2014 Feb 12.

16.

Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis.

Technau KG, Schomaker M, Kuhn L, Moultrie H, Coovadia A, Eley B, Rabie H, Wood R, Cox V, Vizcaya LS, Muchiri E, Davies MA; IeDEA Southern Africa Paediatric Collaboration.

Pediatr Infect Dis J. 2014 Jun;33(6):617-22. doi: 10.1097/INF.0000000000000222.

17.

The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants.

Whitehead N, Potterton J, Coovadia A.

AIDS Care. 2014 Apr;26(4):497-504. doi: 10.1080/09540121.2013.841828. Epub 2013 Oct 14.

PMID:
24125015
18.

Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children.

Technau KG, Lazarus E, Kuhn L, Abrams EJ, Sorour G, Strehlau R, Reubenson G, Davies MA, Coovadia A.

Pediatr Infect Dis J. 2013 Aug;32(8):851-5. doi: 10.1097/INF.0b013e31828c3738.

19.

Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus.

Shiau S, Arpadi S, Strehlau R, Martens L, Patel F, Coovadia A, Abrams EJ, Kuhn L.

J Pediatr. 2013 Jun;162(6):1138-45, 1145.e1-2. doi: 10.1016/j.jpeds.2012.11.025. Epub 2013 Jan 11.

20.

Adherence and viral suppression among infants and young children initiating protease inhibitor-based antiretroviral therapy.

Teasdale CA, Abrams EJ, Coovadia A, Strehlau R, Martens L, Kuhn L.

Pediatr Infect Dis J. 2013 May;32(5):489-94. doi: 10.1097/INF.0b013e31827e84ba.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk